UBCare Co Ltd
KOSDAQ:032620
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
UBCare Co Ltd
Note Receivable
UBCare Co Ltd
Note Receivable Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Note Receivable | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
U
|
UBCare Co Ltd
KOSDAQ:032620
|
Note Receivable
₩2.9B
|
CAGR 3-Years
13%
|
CAGR 5-Years
11%
|
CAGR 10-Years
9%
|
|
|
I
|
Infinitt Healthcare Co Ltd
KOSDAQ:071200
|
Note Receivable
₩15.7B
|
CAGR 3-Years
181%
|
CAGR 5-Years
63%
|
CAGR 10-Years
88%
|
|
|
L
|
LifeSemantics Corp
KOSDAQ:347700
|
Note Receivable
₩5.9m
|
CAGR 3-Years
2 351%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
e
|
ezCaretech Co Ltd
KOSDAQ:099750
|
Note Receivable
₩88.9m
|
CAGR 3-Years
-72%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
L
|
Lunit Inc
KOSDAQ:328130
|
Note Receivable
₩85.5m
|
CAGR 3-Years
-48%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
J
|
JLK Inc
KOSDAQ:322510
|
Note Receivable
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
UBCare Co Ltd
Glance View
UBcare Co., Ltd. engages in the provision of healthcare solutions. The company is headquartered in Seoul, Seoul. The firm mainly operates in two segments. The Medical Information Platform segment provides integrated information solutions providing medical services. The Personal Health Information Management Platform segment provides health management services. In addition, the Company distributes medical instrument and green agricultural products, as well as operates electronic commerce business.
See Also
What is UBCare Co Ltd's Note Receivable?
Note Receivable
2.9B
KRW
Based on the financial report for Dec 31, 2025, UBCare Co Ltd's Note Receivable amounts to 2.9B KRW.
What is UBCare Co Ltd's Note Receivable growth rate?
Note Receivable CAGR 10Y
9%
Over the last year, the Note Receivable growth was 67%. The average annual Note Receivable growth rates for UBCare Co Ltd have been 13% over the past three years , 11% over the past five years , and 9% over the past ten years .
